Skip to main content
. 2011 Nov 2;7(1):92–100. doi: 10.2215/CJN.05440611

Table 1.

Demographic and patient characteristics

Patient Characteristics All Patients Facilities Where <90% of Patients Have the Same DNa (Individualized DNa) Facilities Where 90%–100% of Patients Have the Same DNa (Nonindividualized)
N facilities (N patients)a 1,062 (29,593) 425 (13,069 = 44%) 535 (16,282 = 55%)
Male 60 59 60
Residual renal function 44 47 41
Diabetesb 37 35 38
Black race 6 6 6
Comorbidities
 hypertension 81 82 80
 coronary artery disease 41 43 40
 CVD other 34 37 33
 congestive heart failure 30 30 30
 peripheral vascular disease 26 29 24
 cerebrovascular disease 16 17 16
 psychiatric disorder 16 18 14
 cancer 13 14 12
 lung disease 11 12 10
 neurologic disease 10 11 10
 recurrent cellulitis 8 8 7
 gastrointestinal bleed 5 5 5
 HIV 1 1 1
Vascular access
 AVF 64 62 65
 catheter 22 24 21
 graft 9 8 9
 unknown access 5 5 6
Age (yr) 63.0 ± 14.7 63.0 ± 15.0 63.0 ± 14.4
Vintage (yr) 1.9 (0.3–5.5) 1.6 (0.3–5.0) 2.1 (0.4–5.9)
Body mass index (kg/m2) 23.6 (20.7–27.2) 24.3 (21.4–27.8) 23.1 (20.2–26.7)
IDWG (% of body weight) 3.04 ± 1.91 2.95 ± 1.94 3.12 ± 1.89
Predialysis SBP (mmHg) 144.5 ± 24.4 141.8 ± 24.4 146.6 ± 24.3
Laboratory parameters
 albumin (g/dl) 3.68 ± 0.53 3.70 ± 0.55 3.67 ± 0.52
 creatinine (mg/dl) 8.7 ± 3.1 8.4 ± 3.0 8.9 ± 3.2
 ferritin (ng/ml) 288 (130–538) 305 (146–549) 270 (116–527)
 hemoglobin (g/dl) 10.9 ± 1.7 11.1 ± 1.7 10.8 ± 1.7
 white blood cells (1000/mm3) 7.1 ± 2.5 7.3 ± 2.5 6.9 ± 2.5
 predialysis SNa (mEq/L) 138.2 ± 3.5 138.2 ± 3.6 138.3 ± 3.5
Prescribed DNa (mEq/L) 139.9 ± 1.9 140.0 ± 2.3 139.8 ± 1.4
Calculated GNa (mEq/L) 1.7 ± 3.9 1.8 ± 4.2 1.5 ± 3.7

Continuous variables expressed as means ±SD, except non–normally distributed variables, which are expressed as median (interquartile range). Categorical variables are expressed as percentages. DNa, dialysate sodium concentration (prescribed); SNa, predialysis serum sodium concentration; GNa, dialysate–to–serum sodium gradient (calculated); IDWG, interdialytic weight gain; SBP, systolic BP; CVD, cardiovascular disease; AVF, arteriovenous fistula.

a

Columns do not sum because only facilities with sufficient data (n≥5 data points/patients) were included in facility analyses.

b

Diabetes as comorbid condition or cause of ESRD.